$1,110,000 of DAVITA INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program Issues related to Veterans Affairs and dialysis H.R. 3944, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, provisions related to dialysis"
You can find more data on corporate lobbying on Quiver Quantitative.
DVA Congressional Stock Trading
Members of Congress have traded $DVA stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DVA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DVA Insider Trading Activity
DVA insiders have traded $DVA stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:
- HATHAWAY INC BERKSHIRE has made 0 purchases and 2 sales selling 2,037,476 shares for an estimated $284,372,012.
- JAMES O HEARTY (Chief Compliance Officer) sold 2,351 shares for an estimated $352,650
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DVA Hedge Fund Activity
We have seen 210 institutional investors add shares of DVA stock to their portfolio, and 356 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BERKSHIRE HATHAWAY INC removed 1,635,962 shares (-4.8%) from their portfolio in Q3 2025, for an estimated $217,370,270
- BLACKROCK, INC. removed 537,342 shares (-13.1%) from their portfolio in Q3 2025, for an estimated $71,396,631
- VANGUARD GROUP INC removed 519,622 shares (-10.9%) from their portfolio in Q3 2025, for an estimated $69,042,175
- PACER ADVISORS, INC. removed 455,260 shares (-97.6%) from their portfolio in Q3 2025, for an estimated $60,490,396
- CITADEL ADVISORS LLC added 306,237 shares (+212.7%) to their portfolio in Q3 2025, for an estimated $40,689,710
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 289,725 shares (+109.7%) to their portfolio in Q3 2025, for an estimated $38,495,760
- NEUBERGER BERMAN GROUP LLC added 269,015 shares (+138.5%) to their portfolio in Q3 2025, for an estimated $35,744,023
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DVA Analyst Ratings
Wall Street analysts have issued reports on $DVA in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Underperform" rating on 09/10/2025
To track analyst ratings and price targets for DVA, check out Quiver Quantitative's $DVA forecast page.
DVA Price Targets
Multiple analysts have issued price targets for $DVA recently. We have seen 3 analysts offer price targets for $DVA in the last 6 months, with a median target of $140.0.
Here are some recent targets:
- Ryan Langston from TD Cowen set a target price of $133.0 on 11/03/2025
- Andrew Mok from Barclays set a target price of $143.0 on 10/30/2025
- Kevin Fischbeck from B of A Securities set a target price of $140.0 on 09/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
